Alpha 2.0
Login Register
» Authors » Shitong Qiao

Shitong Qiao

Explore the profile of Shitong Qiao including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 8
Citations 170
Followers 0
Related Specialties
General Medicine
Biology
Biomedical Engineering
Top 10 Co-Authors
Xin Zhao
George Fu Gao
Rong Zhang
Lei Dong
Yueyun Ma
Wenjing Ruan
Yanhua Li
Anqi Zheng
Qihui Wang
George F Gao
Published In
N Engl J Med
EBioMedicine
Lancet Reg Health West Pac
Cell Discov
Nat Commun
Affiliations
Soon will be listed here.
Recent Articles
1.
SARS-CoV-2 serotyping based on spike antigenicity and its implications for host immune evasion
Ruan W, Gao P, Qu X, Jiang J, Zhao Z, Qiao S, et al.
EBioMedicine . 2025 Mar; 114:105634. PMID: 40080947
Background: As SARS-CoV-2 continues to spread and evolve, new variants/sub-variants emerge, raising concerns about vaccine-induced immune escape. Here, we conducted a systematic analysis of the serology and immunogenicity of major...
2.
Multi-omic characteristics of longitudinal immune profiling after breakthrough infections caused by Omicron BA.5 sublineages
Li Y, Qin S, Dong L, Xiao Y, Zhang Y, Hou Y, et al.
EBioMedicine . 2024 Nov; 110:105428. PMID: 39536392
Background: Omicron sub-variants breakthrough infections (BTIs) have led to millions of coronavirus disease 2019 (COVID-19) cases worldwide. The acute-phase immune status is critical for prognosis, however, the dynamic immune profiling...
3.
Single-cell multi-omics analysis revealing immune features of inactivated COVID-19 vaccination in systemic lupus erythematosus patients
Zheng Y, Wang S, Zhou X, Qiao S, Zhao X, Chen Y, et al.
Sci Bull (Beijing) . 2024 Jun; 70(1):42-46. PMID: 38851910
No abstract available.
4.
Long-term effects of Omicron BA.2 breakthrough infection on immunity-metabolism balance: a 6-month prospective study
Li Y, Qin S, Dong L, Qiao S, Wang X, Yu D, et al.
Nat Commun . 2024 Mar; 15(1):2444. PMID: 38503738
There have been reports of long coronavirus disease (long COVID) and breakthrough infections (BTIs); however, the mechanisms and pathological features of long COVID after Omicron BTIs remain unclear. Assessing long-term...
5.
Antibody response assessment of immediate breakthrough infections after zero-COVID policy adjustment in China
Li Y, Qiao S, Dong L, Zhang R, Li R, Qin S, et al.
Lancet Reg Health West Pac . 2023 Nov; 40:100945. PMID: 38033432
No abstract available.
6.
An updated atlas of antibody evasion by SARS-CoV-2 Omicron sub-variants including BQ.1.1 and XBB
He Q, Wu L, Xu Z, Wang X, Xie Y, Chai Y, et al.
Cell Rep Med . 2023 Apr; 4(4):100991. PMID: 37019110
Emerging Omicron sub-variants are causing global concerns, and their immune evasion should be monitored continuously. We previously evaluated the escape of Omicron BA.1, BA.1.1, BA.2, and BA.3 from an atlas...
7.
Broader-species receptor binding and structural bases of Omicron SARS-CoV-2 to both mouse and palm-civet ACE2s
Li L, Han P, Huang B, Xie Y, Li W, Zhang D, et al.
Cell Discov . 2022 Jul; 8(1):65. PMID: 35821014
The Omicron variant of SARS-CoV-2 carries multiple unusual mutations, particularly in the receptor-binding domain (RBD) of the spike (S) protein. Moreover, host-adapting mutations, such as residues 493, 498, and 501,...
8.
Omicron SARS-CoV-2 Neutralization from Inactivated and ZF2001 Vaccines
Zhao X, Zhang R, Qiao S, Wang X, Zhang W, Ruan W, et al.
N Engl J Med . 2022 Jul; 387(3):277-280. PMID: 35793198
No abstract available.
9.
Effects of a Prolonged Booster Interval on Neutralization of Omicron Variant
Zhao X, Li D, Ruan W, Chen Z, Zhang R, Zheng A, et al.
N Engl J Med . 2022 Jan; 386(9):894-896. PMID: 35081296
No abstract available.